Cargando…

Visual disability in neuromyelitis optica spectrum disorders: prognostic prediction models

BACKGROUND AND OBJECTIVES: Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune inflammatory disease of the central nervous system characterized by simultaneous or consecutive episodes of acute optic neuritis and transverse myelitis. Attacks of NMOSD can result in the accrual of severe vi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Wenqin, Kong, Lingyao, Chen, Hongxi, Wang, Xiaofei, Du, Qin, Shi, Ziyan, Zhou, Hongyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282746/ https://www.ncbi.nlm.nih.gov/pubmed/37350969 http://dx.doi.org/10.3389/fimmu.2023.1209323

Ejemplares similares

Granzyme B in circulating CD8+ T cells as a biomarker of immunotherapy effectiveness and disability in neuromyelitis optica spectrum disorders
por: Shi, Ziyan, et al.
Publicado: (2022)

Initial BMI effects on clinical presentation and prognosis in neuromyelitis optica spectrum disorder
por: Luo, Wenqin, et al.
Publicado: (2023)

The causal relationship between neuromyelitis optica spectrum disorder and other autoimmune diseases
por: Wang, Xiaofei, et al.
Publicado: (2022)

Identifying different cognitive phenotypes and their relationship with disability in neuromyelitis optica spectrum disorder
por: Kong, Lingyao, et al.
Publicado: (2022)

Effects of pregnancy on neuromyelitis optica spectrum disorder and predictors of related attacks
por: Du, Qin, et al.
Publicado: (2022)

COVID-19 and the risk of neuromyelitis optica spectrum disorder: a Mendelian randomization study
por: Sun, Dongren, et al.
Publicado: (2023)

Retinal structural and microvascular changes in myelin oligodendrocyte glycoprotein antibody disease and neuromyelitis optica spectrum disorder: An OCT/OCTA study
por: Lang, Yanlin, et al.
Publicado: (2023)

Relapses after SARS-CoV-2 vaccination in patients with neuromyelitis optica spectrum disorder and multiple sclerosis
por: Kong, Lingyao, et al.
Publicado: (2022)

Mortality of neuromyelitis optica spectrum disorders in a Chinese population
por: Du, Qin, et al.
Publicado: (2021)

Relationship between the Clinical Characteristics in Patients with Neuromyelitis Optica Spectrum Disorders and Clinical Immune Indicators: A Retrospective Study
por: Cai, Linjun, et al.
Publicado: (2022)

Immune Repertoire Profiling Reveals Its Clinical Application Potential and Triggers for Neuromyelitis Optica Spectrum Disorders
por: Miao, Yu, et al.
Publicado: (2023)

CD8(+) T cell subpopulations and pro‐inflammatory cytokines in neuromyelitis optica spectrum disorder
por: Shi, Ziyan, et al.
Publicado: (2020)

Age of onset correlates with clinical characteristics and prognostic outcomes in neuromyelitis optica spectrum disorder
por: Hu, Yacen, et al.
Publicado: (2022)

Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014)

Complement biomarkers reflect the pathological status of neuromyelitis optica spectrum disorders
por: Miyamoto, Katsuichi, et al.
Publicado: (2023)

Research hotspots and trends on neuromyelitis optica spectrum disorders: insights from bibliometric analysis
por: Chen, Xin, et al.
Publicado: (2023)

Visual Evoked Potentials in Neuromyelitis Optica Spectrum Disorders
por: Hernandez Fustes, Otto Jesus, et al.
Publicado: (2021)

Neuromyelitis Optica Spectrum Disorder
por: Cazzaniga, Juliana, et al.
Publicado: (2023)

Effectiveness and tolerability of different therapies in preventive treatment of MOG-IgG-associated disorder: A network meta-analysis
por: Wang, Xiaofei, et al.
Publicado: (2022)

A Comprehensive Review on the Role of Genetic Factors in Neuromyelitis Optica Spectrum Disorder
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2021)

Rare variants and HLA haplotypes associated in patients with neuromyelitis optica spectrum disorders
por: Tabansky, Inna, et al.
Publicado: (2022)

Neuromyelitis Optica Spectrum Disorder With Anti-Aquaporin-4 Antibody: Outcome Prediction Models
por: Wang, Liang, et al.
Publicado: (2022)

Expression and Clinical Correlation Analysis Between Repulsive Guidance Molecule a and Neuromyelitis Optica Spectrum Disorders
por: Tang, Jinhua, et al.
Publicado: (2022)

Early Initiation of Tocilizumab Treatment Against Moderate-to-Severe Myelitis in Neuromyelitis Optica Spectrum Disorder
por: Du, Chen, et al.
Publicado: (2021)

Factors influencing the degree of disability in patients with neuromyelitis optica spectrum disorders
por: Shi, Lili, et al.
Publicado: (2023)

Thymic Involution and Altered Naive CD4 T Cell Homeostasis in Neuromyelitis Optica Spectrum Disorder
por: Chang, Haoxiao, et al.
Publicado: (2021)

Neuromyelitis optica spectrum disorders: An update
por: Pandit, Lekha
Publicado: (2015)

Treatment of Neuromyelitis Optica Spectrum Disorders
por: Chan, Koon-Ho, et al.
Publicado: (2021)

Satralizumab for neuromyelitis optica spectrum disorder
Publicado: (2021)

Risk Factors and Nomogram for Predicting Relapse Risk in Pediatric Neuromyelitis Optica Spectrum Disorders
por: Zhang, Shanchao, et al.
Publicado: (2022)

Muscle damage in patients with neuromyelitis optica spectrum disorder
por: Chen, Hong-xi, et al.
Publicado: (2017)

Effects of Tocilizumab Therapy on Circulating B Cells and T Helper Cells in Patients With Neuromyelitis Optica Spectrum Disorder
por: Liu, Ye, et al.
Publicado: (2021)

Progressive patterns of neurological disability in multiple sclerosis and neuromyelitis optica spectrum disorders
por: Akaishi, Tetsuya, et al.
Publicado: (2020)

Disability Outcomes in the N-MOmentum Trial of Inebilizumab in Neuromyelitis Optica Spectrum Disorder
por: Marignier, Romain, et al.
Publicado: (2021)

Autoantibodies Against the Complement Regulator Factor H in the Serum of Patients With Neuromyelitis Optica Spectrum Disorder
por: Uzonyi, Barbara, et al.
Publicado: (2021)

Association of Circulating Follicular Helper T Cells and Serum CXCL13 With Neuromyelitis Optica Spectrum Disorders
por: Yang, Xiaoyan, et al.
Publicado: (2021)

Neuromyelitis optica spectrum disorder in Western China impacts employment and increases financial burden in women
por: Han, Lin, et al.
Publicado: (2022)

Circulating Memory T Follicular Helper Cells in Patients with Neuromyelitis Optica/Neuromyelitis Optica Spectrum Disorders
por: Fan, Xueli, et al.
Publicado: (2016)

Brain Abnormalities in Neuromyelitis Optica Spectrum Disorder
por: Kim, Woojun, et al.
Publicado: (2012)

Sleep abnormality in neuromyelitis optica spectrum disorder
por: Song, Yijun, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3a8feo6m1kihno8ju763ptq117